Zortress User Reviews & Ratings
Zortress has an average rating of 10.0 out of 10 from a total of 1 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Organ Transplant, Rejection Prophylaxis | 1 reviews for Organ Transplant, Rejection Prophylaxis | 15 medications |
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about Zortress (everolimus)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: mTOR inhibitors
- Breastfeeding
- En español
For Organ Transplant, Rejection Prophylaxis "This is an exceptionally good drug for liver transplants. In fact, it is a monotherapy for me. One of the big selling points is that it does not create problems with kidneys, heart, lungs, etc. as other drugs can and do down the road. I started with 6 mg/day - went through an acute rejection at 6 weeks post-transplant (jumped up to 8 mg/day and steroids) and weaned back down to a monotherapy and 6 mg in the first two years. After it was discovered that this drug had no impact on my neuroendocrine tumor progression, I quit the study and found a physician who would work with me to lower this drug. I am currently on 2 mg (subclinical dose) and doing fine, 8 years post-transplant. I recommend this drug and say just be patient if you are a new transplant person. After about 1.5 years, push to get off all other drugs except this one, you will have fewer problems in the long run."